BAP1 and Miyoshi myopathy: Common genomic alterations and similar genomic profiles, e.g. loss of tumor suppressors (NF2, LATS2, BAP1) in murine and human MM emphasize the relevance of mouse model systems to study mesotheliomagenesis [8] and to possibly validate suggested MM biomarkers.